President's Message
News and Events
About CBTRUS
Acknowledgements
Funding
Board of Directors
Board of Advisors
Personnel
Reports and Tables
Manuscripts
Fact Sheet
Data Analysis Request
Links
Glossary
Contact Information
Home
Manuscripts

CBTRUS manuscripts

PUBLISHED

Villano JL, Bressler L, Propp JM, Valyi-Nagy T, Martin IK, Dolecek TA, McCarthy BJ. Descriptive Epidemiology of Selected Olfactory Tumors. J Neuro-Oncol. Feb 13, 2010.[Epub ahead of print].

Villano JL, Virk IY, Ramirez V, Propp JM, Engelhard HH, McCarthy BJ. Descriptive Epidemiology of Central Nervous System Germ Cell Tumors: Non-Pineal Analysis. Neuro-Oncology. 2010; 12:257-64.

McCarthy BJ, Schellinger KA, Propp JM, Kruchko C, Malmer B. A Case for the Worldwide Collection of Primary Benign Brain Tumors. Neuroepidemiology 33(3):268-275, 2009.

Curran EK, Le GM, Sainani KL, Propp JM, Fisher PG. Do Children and Adults Differ in Survival from Medulloblastoma? A Study from the SEER Registry. Journal of Neuro-Oncology 95(1):81-5, 2009.

Curran EK, Sainani KL, Le GM, Propp JM, Fischer PG. Gender Affects Survival from Medulloblastoma Only in Older Children and Adults: A Study from the Surveillance Epidemiology and End Results Registry. Pediatric Blood and Cancer 52(1):60-64, 2009.

McCarthy BJ, Propp JM, Davis FG, Burger PC. Time trends in oligodendroglial and astrocytic tumor incidence. Neuroepidemiology, 30:34-44, 2008.

Schellinger KA, Propp JM, Villano JL, McCarthy BJ. Descriptive epidemiology of primary spinal cord tumors. Journal of Neuro-Oncology, 87: 173-179, 2008.

Villano JL, Propp JM, Porter KR, Stewart AK, Valyi-Nagy T, Li X, Engelhard HE, McCarthy BJ. Malignant pineal germ cell tumors: An analysis of cases from three tumor registries. Neuro-Oncology, 10: 121-130, 2008.

Barnholtz–Sloan JS, Kruchko C. Meningiomas: causes and risk factors. Neurosurgical Focus, 23:E2, 2007.

Hoffman S, Schellinger KA, Propp JM, McCarthy BJ, Campbell RT, Davis FG. Seasonal variation in incidence of pediatric medulloblastoma in the United States, 1995–2001. Neuroepidemiology, 29:89–95, 2007.

Thuppal S, Propp JM, McCarthy BJ. Average years of potential life lost in those who have died from brain and CNS Tumors in the United States. Neuroepidemiology, 27: 22-27, 2006.

Hoffman S, Propp JM, McCarthy BJ. Temporal trends in incidence of primary brain tumors in the United States, 1985-1999. Neuro-Oncology [serial online], Doc. 05-032, December 5, 2005. URL <neuro-oncology.mc.duke.edu>

Propp JM, McCarthy BJ, Davis FG, Preston-Martin S. Descriptive epidemiology of vestibular schwannomas. Neuro-Oncology [serial online], Doc. 04-109, November 29, 2005. URL <neuro-oncology.mc.duke.edu>

McCarthy BJ, Kruchko C, and Central Brain Tumor Registry of the United States. Consensus conference on cancer registration of brain and central nervous system tumors. Neuro-Oncology, 7(2), 2005. (Posted to Neuro-Oncology [serial online], Doc. 04-050, February 11, 2005. URL <neuro-oncology.mc.duke.edu>)

Castillo MS, Davis FG, Surawicz T, Bruner JM, Bigner S, Coons S, Bigner DD. Consistency of primary brain tumor diagnoses and codes in cancer surveillance systems. Neuroepidemiology, 23:85-93, 2004.

McCarthy BJ, Surawicz T, Bruner JM, Kruchko C, Davis F. Consensus conference on brain tumor definition for registration. Neuro-Oncology. 4(2):134-145, 2002 (Posted to Neuro-Oncology [serial online], Doc. 01-059, February 21, 2002. URL <neuro-oncology.mc.duke.edu>)

Gershman ST, Surawicz TA, McLaughlin R, Rousseau D. Completeness of reporting of brain and other central nervous system neoplasms. Journal of Registry Management, 28:167-170, 2001.

Davis FG and McCarthy BJ. Current epidemiological trends and surveillance issues in brain tumors. Expert Review of Anticancer Therapy, 1:395-401, 2001.

Davis FG, Kupelian V, Freels S, McCarthy B, Surawicz T. Prevalence estimates for primary brain tumors in the United States by behavior and major histology groups. Neuro-Oncology, 3:152-158, 2001. (Posted to Neuro-Oncology [serial online], Doc. 00-056, June 5, 2001. URL<neuro-oncology.mc.duke.edu>)

Jukich PJ, McCarthy BJ, Surawicz TS, Freels S, Davis FG. Trends in incidence of primary brain tumors in the United States, 1985-1994. Neuro-Oncology, 3:141-151, 2001. (Posted to Neuro-Oncology [serial online], Doc. 00-055, June 5, 2001. URL<neuro-oncology.mc.duke.edu>)

Surawicz TS, Kupelian VA, Davis FG. Changes in age-adjusted disease incidence using the year 2000 standard population: an example using data from the Central Brain Tumor Registry of the United States. Journal of Registry Management, 28:6164, 2001.

Davis FG and McCarthy BJ. Epidemiology of brain tumors. Current Opinion in Neurology, 13:635-640, 2000.

Surawicz TS, McCarthy BJ, Jukich PJ, Davis FG. The accuracy and completeness of primary brain and central nervous system tumor data: results from the Central Brain Tumor Registry of the United States. Journal of Registry Management, 27:5155, 2000.

Davis FG, McCarthy B, Jukich P. The descriptive epidemiology of brain tumors. Neuroimaging Clinics of North America, 9:581-594, 1999.

Davis FG, McCarthy BJ, Berger MS. Centralized databases available for describing primary brain tumor incidence, survival, and treatment: Central Brain Tumor Registry of the United States; Surveillance, Epidemiology, and End Results; and National Cancer Data Base. Neuro-Oncology, 1:205-211, 1999. (Posted to Neuro-Oncology [serial online], Doc. 98-22, June 3, 1999. URL <neuro-oncology.mc.duke.edu>)

Surawicz TS, McCarthy BJ, Kupelian V, Jukich PJ, Bruner JM, Davis FG. Descriptive epidemiology of primary brain and CNS tumors: results from the Central Brain Tumor Registry of the United States, 1990-1994. Neuro-Oncology, 1:14-25, 1999. (Posted to Neuro-Oncology [serial online], Doc. 98-04, January 19, 1999. URL <neuro-oncology.mc.duke.edu>)

Davis FG, McCarthy BJ, Freels S, Kupelian V, Bondy ML. The conditional probability of survival of patients with primary malignant brain tumors: Surveillance, Epidemiology, and End Results (SEER) data. Cancer, 85:485-491, 1999.

Gurney JG, Wall DA, Jukich PJ, Davis FG. The contribution of nonmalignant tumors to CNS tumor incidence rates among children in the United States. Cancer Causes and Control, 10:101-105, 1999.

Surawicz TS, Davis F, Freels S, Laws ER Jr, Menck HR. Brain tumor survival: results from the National Cancer Data Base. Journal of Neuro-Oncology, 40:151-160, 1998.

Bunin GR, Surawicz TS, Witman PA, Preston-Martin S, Davis F, Bruner JM. The descriptive epidemiology of craniopharyngioma. Journal of Neurosurgery, 89:547-551, 1998.

McCarthy BJ, Davis FG, Freels S, Surawicz TS, Damek DM, Grutsch J, Menck HR, Laws ER Jr. Factors associated with survival in patients with meningioma. Journal of Neurosurgery, 88:831-839, 1998.

Davis FG, Freels S, Grutsch J, Barlas S, Brem S. Survival rates in patients with primary malignant brain tumors stratified by patient age and tumor histological type: an analysis based on Surveillance, Epidemiology, and End Results (SEER) data, 19731991. Journal of Neurosurgery, 88:1-10, 1998.

Bunin GR, Surawicz TS, Witman PA, Preston-Martin S, Davis F, Bruner JM. The descriptive epidemiology of craniopharyngioma. Neurosurgical Focus, 3(6):Article 1, December 1997.

McCarthy BJ, Davis F, Freels S, Surawicz TS, Damek D, Grutsch J, Menck HR, Laws ER Jr. Factors associated with survival in patients with meningioma. Neurosurgical Focus, 2(4):Article 1, April 1997.

Davis FG, Bruner JM, Surawicz TS. The rationale for standardized registration and reporting of brain and central nervous system tumors in population-based cancer registries. Neuroepidemiology, 16:308-316, 1997.

Davis FG, Malinski N, Haenszel W, Chang J, Flannery J, Gershman S, Dibble R, Bigner DD. Primary brain tumor incidence rates in four United States regions, 1985-1989: a pilot study. Neuroepidemiology, 15:103-112, 1996.